KR20040089633A - 경구 또는 직장내 투여용 조성물 - Google Patents

경구 또는 직장내 투여용 조성물 Download PDF

Info

Publication number
KR20040089633A
KR20040089633A KR10-2004-7012595A KR20047012595A KR20040089633A KR 20040089633 A KR20040089633 A KR 20040089633A KR 20047012595 A KR20047012595 A KR 20047012595A KR 20040089633 A KR20040089633 A KR 20040089633A
Authority
KR
South Korea
Prior art keywords
composition
lipid
agents
tablet
agent
Prior art date
Application number
KR10-2004-7012595A
Other languages
English (en)
Korean (ko)
Inventor
헐스로프벤트
Original Assignee
엘티피 리피드 테크놀로지스 프로바이더 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엘티피 리피드 테크놀로지스 프로바이더 아베 filed Critical 엘티피 리피드 테크놀로지스 프로바이더 아베
Publication of KR20040089633A publication Critical patent/KR20040089633A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
KR10-2004-7012595A 2002-02-15 2003-02-14 경구 또는 직장내 투여용 조성물 KR20040089633A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200475-2 2002-02-15
SE0200475A SE0200475D0 (sv) 2002-02-15 2002-02-15 Oral farmaceutisk beredning
PCT/SE2003/000251 WO2003068267A1 (en) 2002-02-15 2003-02-14 Composition for oral or rectal administration

Publications (1)

Publication Number Publication Date
KR20040089633A true KR20040089633A (ko) 2004-10-21

Family

ID=20286999

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7012595A KR20040089633A (ko) 2002-02-15 2003-02-14 경구 또는 직장내 투여용 조성물

Country Status (20)

Country Link
US (1) US20050181042A1 (ja)
EP (1) EP1474174B1 (ja)
JP (1) JP2005520816A (ja)
KR (1) KR20040089633A (ja)
CN (1) CN101060862A (ja)
AT (1) ATE430585T1 (ja)
AU (1) AU2003206355B2 (ja)
BR (1) BR0313651A2 (ja)
CA (1) CA2475025C (ja)
DE (1) DE60327511D1 (ja)
DK (1) DK1474174T3 (ja)
ES (1) ES2324603T3 (ja)
MX (1) MXPA04007946A (ja)
NZ (1) NZ534812A (ja)
PT (1) PT1474174E (ja)
RU (1) RU2302260C2 (ja)
SE (1) SE0200475D0 (ja)
SI (1) SI1474174T1 (ja)
WO (1) WO2003068267A1 (ja)
ZA (1) ZA200406399B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
SE0400233D0 (sv) * 2004-02-04 2004-02-04 Ltp Lipid Technologies Provide Rektal komposition
WO2006115463A1 (en) * 2005-04-28 2006-11-02 Galenica Technology Ab Pharmaceutical dosage forms comprising a lipid phase
WO2007098446A2 (en) * 2006-02-21 2007-08-30 Accu-Break Pharmaceuticals, Inc. Method for minimizing variation in dosage forms
CN101278928B (zh) 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 含左卡尼汀或其衍生物的药物组合物及其用途
CN101991557B (zh) * 2009-08-10 2013-09-18 杭州赛利药物研究所有限公司 一种盐酸万古霉素液体胶囊及其制备方法
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
CN102631290A (zh) * 2012-04-05 2012-08-15 韩昌志 一种生产栓剂的综合法
US10456327B2 (en) 2015-08-28 2019-10-29 Craig Robertson Package for frozen nutrient pill

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7812466A (nl) * 1978-12-22 1980-06-24 Shell Int Research Werkwijze voor de bereiding van gasmengsels.
DE2951142C2 (de) * 1979-12-19 1983-11-03 A. Nattermann & Cie GmbH, 5000 Köln Suppositorium-Zubereitung von Indometacin oder Acemetacin
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
JPH08510989A (ja) * 1992-10-16 1996-11-19 グラクソ、グループ、リミテッド ラニチジン組成物
US5505982A (en) * 1994-01-28 1996-04-09 Fmc Corporation Chocolate confection
CN1091591C (zh) * 1994-02-04 2002-10-02 利珀克尔集团公司 亲脂载体制剂
JP2948111B2 (ja) * 1994-09-16 1999-09-13 塩野義製薬株式会社 経口投与用油性組成物
DE29511421U1 (de) * 1995-07-14 1995-10-12 Chou, Wen San, An Ting, Tainan Luftkompressor
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
ID21009A (id) * 1997-10-08 1999-04-08 Taisho Pharmaceutical Co Ltd Komposisi untuk supositori
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
JP4116436B2 (ja) * 2000-12-14 2008-07-09 エフ．ホフマン−ラ ロシュ アーゲー 自己乳化脂質マトリックス（ｓｅｌｍ）

Also Published As

Publication number Publication date
SI1474174T1 (sl) 2009-08-31
CN101060862A (zh) 2007-10-24
PT1474174E (pt) 2009-06-25
JP2005520816A (ja) 2005-07-14
CA2475025C (en) 2010-07-27
ES2324603T3 (es) 2009-08-11
NZ534812A (en) 2006-10-27
CA2475025A1 (en) 2003-08-21
WO2003068267A1 (en) 2003-08-21
ATE430585T1 (de) 2009-05-15
DE60327511D1 (de) 2009-06-18
DK1474174T3 (da) 2009-07-06
BR0313651A2 (pt) 2008-11-11
AU2003206355B2 (en) 2007-03-01
EP1474174B1 (en) 2009-05-06
AU2003206355A1 (en) 2003-09-04
MXPA04007946A (es) 2005-06-08
EP1474174A1 (en) 2004-11-10
SE0200475D0 (sv) 2002-02-15
RU2302260C2 (ru) 2007-07-10
ZA200406399B (en) 2005-09-12
RU2004124042A (ru) 2005-06-10
US20050181042A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
US6479545B1 (en) Formulation for menopausal women
FI116199B (fi) Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa
EP2164520B1 (en) Cyclodextrins for administering fatty acids in tablets
US20090041829A1 (en) Pharmaceutical dosage forms comprising a lipid phase
HU211617A9 (en) Biphasic release formulations for lipophilic drugs
MX2011002640A (es) Capsula de polisacarido que comprende una emulsion que contiene aceite de acido graso.
WO1995022982A1 (en) Cyclosporin-containing powder composition
KR20040089633A (ko) 경구 또는 직장내 투여용 조성물
US4842865A (en) Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules
IL158908A (en) Pharmaceutical preparation containing lipase inhibitor and monoester of fatty acid with sucrose
US20090143484A1 (en) Use of garlic oil to increase bioavailability of coenzyme q-10
JP2007504197A (ja) ホスファチジルセリン塩基の生理学的活性組成物
KR101821440B1 (ko) 비타민 d의 14-에피-유사체의 새로운 제제
AU2016700A (en) A pharmaceutical composition comprising cyclosporin in a lipid carrier
GB2465988A (en) Powder or tablet containing unsaturated fatty acid and water insoluble carbohydrate
HRP20060022A2 (en) Semi-solid systems containing azetidine derivatives
AU709068B2 (en) Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
US7202087B2 (en) Anticoagulant composition
JPH0566365B2 (ja)
CA2492417C (en) Formulation for menopausal women
KR20140043256A (ko) 무복계면 오메가3 및 그 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E601 Decision to refuse application